ORMP
Oramed Pharmaceuticals Inc (ORMP) Stock Valuation
Review Oramed Pharmaceuticals Inc (ORMP) valuation with server-rendered company data, supporting context and links to related investor research.
- Price to earnings
- 1.87
- Price to book
- 0.57
- Dividend yield
- 0%
- Return on equity
- 0%
- Premium or discount
- 0%
- Market cap
- $182.20M
Oramed Pharmaceuticals Inc (ORMP) Stock Valuation research
The Oramed Pharmaceuticals Inc valuation page presents the available multiples, profitability measures and BTI fair-value context for ORMP. Valuation should be compared with the company's growth, margins, balance sheet and relevant peers rather than judged by one multiple.
A premium may reflect stronger expected growth or quality, while a discount can reflect risk or weak expectations. Neither condition alone establishes that a stock is attractive or unattractive.